Rankings
▼
Calendar
NUVB Q2 2024 Earnings — Nuvation Bio Inc. Revenue & Financial Results | Market Cap Arena
NUVB
Nuvation Bio Inc.
$2B
Q2 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1M
Gross Profit
$88,000
6.1% margin
Operating Income
-$470M
-32779.4% margin
Net Income
-$462M
-32229.4% margin
EPS (Diluted)
$-1.89
QoQ Revenue Growth
+Infinity%
Cash Flow
Operating Cash Flow
-$37M
Free Cash Flow
-$37M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$595M
Total Liabilities
$338M
Stockholders' Equity
$257M
Cash & Equivalents
$34M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1M
$0
—
Gross Profit
$88,000
$0
—
Operating Income
-$470M
-$26M
-1700.1%
Net Income
-$462M
-$21M
-2140.8%
← FY 2024
All Quarters
Q3 2024 →